Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Bavencio (avelumab) for the Treatment of Metastatic Merkel Cell Carcinoma

Drug (Brand / Generic)

Bavencio / avelumab

Developers

Merck and Pfizer

Product Description

Anti-PD-L1 IgG1 monoclonal antibody

Current Indication

Merkel cell carcinoma

Market Sector

Oncology

Development Status

Approved in the US and Europe
Expand

Go Top